Llwytho...
Design of amphotericin B oral formulation for antifungal therapy
Amphotericin B (AmB) remains the “gold standard” for systemic antifungal therapy, even though new drugs are emerging as the attractive antifungal agents. Since AmB has negligible oral absorption as a consequence of its unfavorable physicochemical characterizations, its use is restricted to parentera...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Drug Deliv |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241147/ https://ncbi.nlm.nih.gov/pubmed/28155335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1225852 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|